Table 5. PCV7 effectiveness.
| Reference | Authors | Year Published | Study | Vaccine | Population | Population |
|---|---|---|---|---|---|---|
| 185 | Black, Shinefield, Hansen et al. | 2001 | a | PCV7 | Infants/Toddlers | USA |
| 186 | Black, Shinefield, Ling et al. | 2002 | Ph IVb | PCV7 | Infants/Toddlers | USA |
| 187 | Whitney, Farley, Hadler et al. | 2003 | c | PCV7 | Infants/Toddlers and Adults | USA |
| 188 | Black, Shinefield, Baxter et al. | 2004 | c | PCV7 | Infants/Toddlers | USA |
| 189 | Whitney, Pilishvili, Farley et al. | 2006 | d | PCV7 | Infants/Toddlers | USA |
| 190 | Sharma, Baughman, Holst et al. | 2013 | e | PCV7 | Infants/Toddlers | USA |
aExpanded postlicensure study of > 200,000 children; bPostlicensure effectiveness in reducing risk of pneumonia; cSurveillance pre and post PCV7 licensure; dPostlicensure effectiveness against vaccine serotypes and catch-up vaccination schedules; eCarriage and IPD pre and post PCV7 licensure.